Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TELIGEN System

K-Number: K213978 · 2022-10-18

Decision Date2022-10-18
Product CodeHRX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

TELIGEN System is a medical device manufactured by Medos International SARL. It received FDA 510(k) clearance on 2022-10-18 under approval number K213978. The device is classified under product code HRX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TELIGEN System?

TELIGEN System is a medical device that received FDA 510(k) clearance on 2022-10-18. It is manufactured by Medos International SARL. The 510(k) number is K213978.

When was TELIGEN System approved by the FDA?

TELIGEN System received FDA 510(k) clearance on 2022-10-18, under approval number K213978.

What company makes TELIGEN System?

TELIGEN System is manufactured by Medos International SARL.

What is the FDA product code for TELIGEN System?

The FDA product code for TELIGEN System is HRX.

Other Devices by Medos International SARL

View all 73 devices →

Related Devices (Code: HRX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.